Arterial embolisation to treat uterine myomata
Haemorrhage, probably related to hypervascularisation, is the commonest complication of uterine myomata and is difficult to treat. 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by sel...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1995-09, Vol.346 (8976), p.671-672 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 672 |
|---|---|
| container_issue | 8976 |
| container_start_page | 671 |
| container_title | The Lancet (British edition) |
| container_volume | 346 |
| creator | Ravina, J.H. Ciraru-Vigneron, N. Bouret, J.M. Herbreteau, D. Houdart, E. Aymard, A. Merland, J.J. |
| description | Haemorrhage, probably related to hypervascularisation, is the commonest complication of uterine myomata and is difficult to treat. 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by selective free-flow arterial embolisation of the myomata with Ivalon particles. With a mean follow-up of 20 months (range 11-48) in the responders, symptoms resolved in 11 patients; menstrual cycles returned to normal in ten of these. Three patients had partial improvement. Two failures required surgery. In 14 cases embolisation caused pelvic pain, which required analgesia in all. |
| doi_str_mv | 10.1016/S0140-6736(95)92282-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77477199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673695922822</els_id><sourcerecordid>77477199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-d13c5f412c114d994338215c1852705b1f6e1b5c7c10e77c2a8d1d1cf02fa2433</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotVZ_QmEPInrYmskmm81JSvELCh5U8Bay2VmI7EdNUqH_3u0HvXqaw_u8M8NDyBToDCjk9-8UOE1zmeW3StwpxgqWshMyBi55Krj8OiXjI3JOLkL4ppTynIoRGUnBeSHUmMzmPqJ3pkmwLfvGBRNd3yWxT6JHE5P1Nu0waTd9a6K5JGe1aQJeHeaEfD49fixe0uXb8-tivkwtZyymFWRW1ByYBeCVUjzLCgbCQiGYpKKEOkcohZUWKEppmSkqqMDWlNWGDfSE3Oz3rnz_s8YQdeuCxaYxHfbroKXkUoJSAyj2oPV9CB5rvfKuNX6jgeqtJ73zpLcStBJ650mzoTc9HFiXLVbH1kHMkF8fchOsaWpvOuvCEcvynCugA_awx3CQ8evQ62AddhYr59FGXfXun0f-AC2Hgto</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77477199</pqid></control><display><type>article</type><title>Arterial embolisation to treat uterine myomata</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EBSCOhost Business Source Complete</source><creator>Ravina, J.H. ; Ciraru-Vigneron, N. ; Bouret, J.M. ; Herbreteau, D. ; Houdart, E. ; Aymard, A. ; Merland, J.J.</creator><creatorcontrib>Ravina, J.H. ; Ciraru-Vigneron, N. ; Bouret, J.M. ; Herbreteau, D. ; Houdart, E. ; Aymard, A. ; Merland, J.J.</creatorcontrib><description>Haemorrhage, probably related to hypervascularisation, is the commonest complication of uterine myomata and is difficult to treat. 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by selective free-flow arterial embolisation of the myomata with Ivalon particles. With a mean follow-up of 20 months (range 11-48) in the responders, symptoms resolved in 11 patients; menstrual cycles returned to normal in ten of these. Three patients had partial improvement. Two failures required surgery. In 14 cases embolisation caused pelvic pain, which required analgesia in all.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(95)92282-2</identifier><identifier>PMID: 7544859</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adult ; Biological and medical sciences ; Embolization, Therapeutic - adverse effects ; Female ; Follow-Up Studies ; Genital system. Mammary gland ; Humans ; Leiomyoma - blood supply ; Leiomyoma - surgery ; Leiomyoma - therapy ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local ; Palliative Care ; Pelvic Pain - etiology ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Uterine Neoplasms - blood supply ; Uterine Neoplasms - surgery ; Uterine Neoplasms - therapy</subject><ispartof>The Lancet (British edition), 1995-09, Vol.346 (8976), p.671-672</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-d13c5f412c114d994338215c1852705b1f6e1b5c7c10e77c2a8d1d1cf02fa2433</citedby><cites>FETCH-LOGICAL-c422t-d13c5f412c114d994338215c1852705b1f6e1b5c7c10e77c2a8d1d1cf02fa2433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673695922822$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3664910$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7544859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ravina, J.H.</creatorcontrib><creatorcontrib>Ciraru-Vigneron, N.</creatorcontrib><creatorcontrib>Bouret, J.M.</creatorcontrib><creatorcontrib>Herbreteau, D.</creatorcontrib><creatorcontrib>Houdart, E.</creatorcontrib><creatorcontrib>Aymard, A.</creatorcontrib><creatorcontrib>Merland, J.J.</creatorcontrib><title>Arterial embolisation to treat uterine myomata</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Haemorrhage, probably related to hypervascularisation, is the commonest complication of uterine myomata and is difficult to treat. 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by selective free-flow arterial embolisation of the myomata with Ivalon particles. With a mean follow-up of 20 months (range 11-48) in the responders, symptoms resolved in 11 patients; menstrual cycles returned to normal in ten of these. Three patients had partial improvement. Two failures required surgery. In 14 cases embolisation caused pelvic pain, which required analgesia in all.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Embolization, Therapeutic - adverse effects</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Genital system. Mammary gland</subject><subject>Humans</subject><subject>Leiomyoma - blood supply</subject><subject>Leiomyoma - surgery</subject><subject>Leiomyoma - therapy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Palliative Care</subject><subject>Pelvic Pain - etiology</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Uterine Neoplasms - blood supply</subject><subject>Uterine Neoplasms - surgery</subject><subject>Uterine Neoplasms - therapy</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotVZ_QmEPInrYmskmm81JSvELCh5U8Bay2VmI7EdNUqH_3u0HvXqaw_u8M8NDyBToDCjk9-8UOE1zmeW3StwpxgqWshMyBi55Krj8OiXjI3JOLkL4ppTynIoRGUnBeSHUmMzmPqJ3pkmwLfvGBRNd3yWxT6JHE5P1Nu0waTd9a6K5JGe1aQJeHeaEfD49fixe0uXb8-tivkwtZyymFWRW1ByYBeCVUjzLCgbCQiGYpKKEOkcohZUWKEppmSkqqMDWlNWGDfSE3Oz3rnz_s8YQdeuCxaYxHfbroKXkUoJSAyj2oPV9CB5rvfKuNX6jgeqtJ73zpLcStBJ650mzoTc9HFiXLVbH1kHMkF8fchOsaWpvOuvCEcvynCugA_awx3CQ8evQ62AddhYr59FGXfXun0f-AC2Hgto</recordid><startdate>19950909</startdate><enddate>19950909</enddate><creator>Ravina, J.H.</creator><creator>Ciraru-Vigneron, N.</creator><creator>Bouret, J.M.</creator><creator>Herbreteau, D.</creator><creator>Houdart, E.</creator><creator>Aymard, A.</creator><creator>Merland, J.J.</creator><general>Elsevier Ltd</general><general>Lancet</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950909</creationdate><title>Arterial embolisation to treat uterine myomata</title><author>Ravina, J.H. ; Ciraru-Vigneron, N. ; Bouret, J.M. ; Herbreteau, D. ; Houdart, E. ; Aymard, A. ; Merland, J.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-d13c5f412c114d994338215c1852705b1f6e1b5c7c10e77c2a8d1d1cf02fa2433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Embolization, Therapeutic - adverse effects</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Genital system. Mammary gland</topic><topic>Humans</topic><topic>Leiomyoma - blood supply</topic><topic>Leiomyoma - surgery</topic><topic>Leiomyoma - therapy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Palliative Care</topic><topic>Pelvic Pain - etiology</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Uterine Neoplasms - blood supply</topic><topic>Uterine Neoplasms - surgery</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ravina, J.H.</creatorcontrib><creatorcontrib>Ciraru-Vigneron, N.</creatorcontrib><creatorcontrib>Bouret, J.M.</creatorcontrib><creatorcontrib>Herbreteau, D.</creatorcontrib><creatorcontrib>Houdart, E.</creatorcontrib><creatorcontrib>Aymard, A.</creatorcontrib><creatorcontrib>Merland, J.J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ravina, J.H.</au><au>Ciraru-Vigneron, N.</au><au>Bouret, J.M.</au><au>Herbreteau, D.</au><au>Houdart, E.</au><au>Aymard, A.</au><au>Merland, J.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arterial embolisation to treat uterine myomata</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1995-09-09</date><risdate>1995</risdate><volume>346</volume><issue>8976</issue><spage>671</spage><epage>672</epage><pages>671-672</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Haemorrhage, probably related to hypervascularisation, is the commonest complication of uterine myomata and is difficult to treat. 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by selective free-flow arterial embolisation of the myomata with Ivalon particles. With a mean follow-up of 20 months (range 11-48) in the responders, symptoms resolved in 11 patients; menstrual cycles returned to normal in ten of these. Three patients had partial improvement. Two failures required surgery. In 14 cases embolisation caused pelvic pain, which required analgesia in all.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>7544859</pmid><doi>10.1016/S0140-6736(95)92282-2</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1995-09, Vol.346 (8976), p.671-672 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77477199 |
| source | MEDLINE; Elsevier ScienceDirect Journals; EBSCOhost Business Source Complete |
| subjects | Adult Biological and medical sciences Embolization, Therapeutic - adverse effects Female Follow-Up Studies Genital system. Mammary gland Humans Leiomyoma - blood supply Leiomyoma - surgery Leiomyoma - therapy Medical sciences Middle Aged Neoplasm Recurrence, Local Palliative Care Pelvic Pain - etiology Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Uterine Neoplasms - blood supply Uterine Neoplasms - surgery Uterine Neoplasms - therapy |
| title | Arterial embolisation to treat uterine myomata |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A33%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arterial%20embolisation%20to%20treat%20uterine%20myomata&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Ravina,%20J.H.&rft.date=1995-09-09&rft.volume=346&rft.issue=8976&rft.spage=671&rft.epage=672&rft.pages=671-672&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(95)92282-2&rft_dat=%3Cproquest_cross%3E77477199%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77477199&rft_id=info:pmid/7544859&rft_els_id=S0140673695922822&rfr_iscdi=true |